Abbott India Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

42 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Annual
Quarterly

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1944

Chairman: Munir Shaikh

Managing Director: Anil Joseph

Group: Abbott India - MNC

Listing: NSE: ABBOTINDIA, BSE: 500488

Headquarters: Mumbai, Maharashtra

Website: www.abbott.co.in

Key Facts

Market cap: R 31,795.22 Cr

Revenue (TTM): R 4,175.69 Cr

Earnings (TTM): R 649.19 Cr

Cash: R 2,197.37 Cr

Total Debt: R 0.00 Cr

Promoters' ownership: 74.99%

Liquidity: High

52 Week range: R 13,959.80 - 18,679.75

Face value: R10.00

Shares outstanding: 2,12,49,302

10 Years Aggregate:

CFO: 2,375.41 Cr
EBITDA: 3,665.92 Cr
Net Profit: 2,729.82 Cr

Stock Performance

Trailing
Annual

Time Period	Abbott India	S&P BSE Healthcare	S&P BSE Mid Cap
YTD	-5.06	6.11	12.35
1 month	1.34	8.99	-1.72
3 months	-0.23	4.41	6.63
1 Year	-13.31	53.44	74.10
3 Years	32.36	18.47	6.39
5 Years	25.36	8.21	13.02
10 Years	25.91	14.10	10.82

As on 16-Apr-2021

Year	Abbott India	S&P BSE Mid Cap	S&P BSE Healthcare
2020	20.01	19.87	61.45
2019	72.50	-3.05	-3.55
2018	35.82	-13.31	-5.89
2017	17.00	48.13	0.49
2016	-19.91	7.97	-12.88
2015	58.06	7.43	15.06
2014	127.73	54.69	47.43

Annual Report (FY20)

Review & Analysis

Mr Contrarian
14-May-2018
R Sukumar, Fund Manager, KP Pharma Fund, on the potential of Pharma Sector
Aabhas Pandya . 09-Feb-2001

News & Announcements